Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors.
Autor: | Calcagno A, Tettoni MC, Simiele M, Trentini L, Montrucchio C, D'Avolio A, Di Perri G, Bonora S |
---|---|
Zdroj: | Journal of Antimicrobial Chemotherapy (JAC); Feb2013, Vol. 68 Issue 2, p482-484, 3p |
Databáze: | Complementary Index |
Externí odkaz: |